Pearl River Capital, LLC Perkinelmer Inc Transaction History

Pearl River Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	N/A	6,497 New	6,497 $786,000
Q4 2022 Feb 13, 2023	BUY	$119.0 - $147.98 $266,322 - $331,179	2,238 New	2,238 $313,000
Q4 2021 Feb 11, 2022	SELL	$166.66 - $201.06 $1.01 Million - $1.22 Million	-6,077 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$151.98 - $190.5 $723,576 - $906,970	4,761 Added 361.78%	6,077 $1.05 Million
Q2 2021 Aug 13, 2021	BUY	$127.81 - $155.84 $168,197 - $205,085	1,316 New	1,316 $203,000
Q2 2020 Aug 10, 2020	SELL	$70.83 - $105.31 $39,452 - $58,657	-557 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$66.71 - $101.73 $37,157 - $56,663	557 New	557 $42,000
Q4 2019 Feb 12, 2020	SELL	$79.1 - $97.45 $69,449 - $85,561	-878 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$79.44 - $98.79 $69,748 - $86,737	878 New	878 $75,000

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.